WASHINGTON (Reuters) - U.S. health regulators have warned Forest Laboratories Inc for promoting its hypertension drug Bystolic to doctors without properly noting the medication’s risk, according to a letter released on Monday.
WASHINGTON (Reuters) - U.S. health regulators have warned Forest Laboratories Inc for promoting its hypertension drug Bystolic to doctors without properly noting the medication’s risk, according to a letter released on Monday.
